Literature DB >> 16310615

Patient reports of symptoms and their treatment at three palliative care projects servicing individuals with HIV/AIDS.

Daniel Karus1, Victoria H Raveis, Carla Alexander, Barbara Hanna, Peter Selwyn, Katherine Marconi, Irene Higginson.   

Abstract

Self-reports of 32 symptoms and their treatments were obtained from patients of three palliative care programs that provide services to seriously ill HIV patients (>or=95% AIDS) in Alabama (n=47), Baltimore (n=91), and New York City (n=117). On average, patients reported 10.9 (SD=7.6) to 12.7 (SD=6.2) symptoms. Pain, lack of energy, and worrying were reported by a majority of patients at all sites, often with a high level of associated distress. For only four symptoms (pain, nausea, difficulty swallowing, and mouth sores) did half or more of patients at all sites experiencing the symptom also report treatment. Less than a third of patients experiencing 12 symptoms (five of six comprising a psychological subscale) reported treatment. Results show that despite the availability of more efficacious treatments, many HIV/AIDS patients continue to experience significant physical and psychological symptomatology. Many of those experiencing symptoms, however, do not perceive their symptoms as being treated.

Entities:  

Mesh:

Year:  2005        PMID: 16310615     DOI: 10.1016/j.jpainsymman.2005.04.011

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  17 in total

1.  Age and racial/ethnic differences in the prevalence of reported symptoms in human immunodeficiency virus-infected persons on antiretroviral therapy.

Authors:  Michael J Silverberg; Lisa P Jacobson; Audrey L French; Mallory D Witt; Stephen J Gange
Journal:  J Pain Symptom Manage       Date:  2009-03-28       Impact factor: 3.612

2.  Palliative Care, Hospice, and Advance Care Planning: Views of People Living with HIV and Other Chronic Conditions.

Authors:  Jacquelyn Slomka; Maryjo Prince-Paul; Allison Webel; Barbara J Daly
Journal:  J Assoc Nurses AIDS Care       Date:  2016-02-12       Impact factor: 1.354

3.  Racial and socioeconomic disparities in the symptom reporting of persons living with HIV.

Authors:  Rebecca Schnall; Karolynn Siegel; Haomiao Jia; Susan Olender; Sabina Hirshfield
Journal:  AIDS Care       Date:  2018-01-22

4.  Patient and provider-reported symptoms in the post-cART era.

Authors:  E J Edelman; K Gordon; A C Justice
Journal:  AIDS Behav       Date:  2011-05

Review 5.  Palliative Care for the Seriously Ill.

Authors:  Amy S Kelley; R Sean Morrison
Journal:  N Engl J Med       Date:  2015-08-20       Impact factor: 91.245

6.  Characteristics of an ambulatory palliative care clinic for HIV-infected patients.

Authors:  Brian A Perry; Andrew O Westfall; Elizabeth Molony; Rodney Tucker; Christine Ritchie; Michael S Saag; Michael J Mugavero; Jessica S Merlin
Journal:  J Palliat Med       Date:  2013-03-11       Impact factor: 2.947

Review 7.  [Treatment of nausea and vomiting with prokinetics and neuroleptics in palliative care patients : a review].

Authors:  G Benze; B Alt-Epping; A Geyer; F Nauck
Journal:  Schmerz       Date:  2012-09       Impact factor: 1.107

8.  Randomized clinical trial of a community navigation intervention to improve well-being in persons living with HIV and other co-morbidities.

Authors:  Allison Webel; Maryjo Prince-Paul; Stephen Ganocy; Evelina DiFranco; Charles Wellman; Ann Avery; Barbara Daly; Jacquelyn Slomka
Journal:  AIDS Care       Date:  2018-11-15

9.  [Treatment of nausea and vomiting with 5HT3 receptor antagonists, steroids, antihistamines, anticholinergics, somatostatinantagonists, benzodiazepines and cannabinoids in palliative care patients : a systematic review].

Authors:  G Benze; A Geyer; B Alt-Epping; F Nauck
Journal:  Schmerz       Date:  2012-09       Impact factor: 1.107

10.  Palliative care for HIV in the era of antiretroviral therapy availability: perspectives of nurses in Lesotho.

Authors:  Megan E Kell; John D Walley
Journal:  BMC Palliat Care       Date:  2009-08-15       Impact factor: 3.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.